Table 3.

Outcomes.

Duration of follow-up (days), median (IQR)	51.0 (25.5–93.0)
Postoperative complications, $n$ (%)	21 (23 %)
Prolonged/persistent pain, $n$ (%), $N=\mathrm{91}$	5 (5 %)
Fistula formation, $n$ (%), $N=\mathrm{91}$	2 (2 %)
Delayed wound healing, $n$ (%), $N=\mathrm{91}$	12 (13 %)
Cellulitis at the site of incision, $n$ (%), $N=\mathrm{91}$	3 (3 %)
Flap coverage, $n$ (%), $N=\mathrm{91}$	6 (7 %)
Negative-pressure wound therapy, $n$ (%), $N=\mathrm{91}$	3 (3 %)
Clinical failure*, $N=\mathrm{91}$	12 (13 %)
Recurrent or secondary bursal infection, $n$ (%)	8 (67 %)
Osteomyelitis, $n$ (%)	4 (33 %)

^* Composite failure defined as the recurrence of the infection with the same organism, reinfection with another organism, or a local complication, such as osteomyelitis, that was not present at the time of diagnosis within 90 d of surgery.